16:02 Dec 20
Glenmark Life Sciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Glenmark Life Sciences Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
45/100
Medium Financial Strength
Valuation
34/100
Mid Valuation
Technical
46/100
Technically Neutral
Strength
6
Weakness
10
Opportunity
1
Threats
0
0.00 %
Dividend Yield
12.42K
Market Cap (Cr)
RSI
75.00 %
Promoter Holding
0.00 %
Net Profit Margin
| Client | Date | Avg Price | Qty | Value(Cr) | Action |
|---|
Download Our App On:
